Successful combined antifungal salvage therapy with liposomal amphothericin B and caspofungin for invasive Aspergillus flavus infection in a child following allogeneic bone marrow transplantation

Acta Biomedica de l'Ateneo Parmense

Volumn 77, Issue SUPPL. 2, 2006, Pages 17-21

  Kriván, Gergely ^a   Sinkó, János ^a   Nagy, Ildikó Zsolnai ^a   Goda, Vera ^a   Reményi, Péter ^a   Bátai, Árpád ^a   Lueff, Sándor ^a   Kapás, Balázs ^a   Réti, Marienn ^a   Tremmel, Anna ^a   Masszi, Tamás ^a  

^a Szent Laszlo Hospital   (Hungary)

Author keywords

Antifungal compounds; Aspergillus flavus; Tolerability

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; CASPOFUNGIN; CYCLOPHOSPHAMIDE; ECHINOCANDIN; FLUCONAZOLE; THYMOCYTE ANTIBODY; VORICONAZOLE;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANAMNESIS; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FLAVUS; CASE REPORT; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CHILD; CLINICAL FEATURE; DOSE RESPONSE; DRUG EFFICACY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY TEST; SALVAGE THERAPY;

AMPHOTERICIN B; ANEMIA, APLASTIC; ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS FLAVUS; BONE MARROW TRANSPLANTATION; CATHETERIZATION, CENTRAL VENOUS; CHILD; CICATRIX; DISEASE PROGRESSION; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; EQUIPMENT CONTAMINATION; FEMALE; HEPATITIS; HUMANS; IMMUNOCOMPROMISED HOST; LEUKOCYTE TRANSFUSION; LIPOSOMES; NECROSIS; PEPTIDES, CYCLIC; PNEUMOTHORAX; POSTOPERATIVE COMPLICATIONS; REMISSION INDUCTION; SALVAGE THERAPY; TORQUE TENO VIRUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 33845340456     PISSN: 03924203     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Bowden RA. Fungal infections after marrow transplantation. In: Bowden RA, Ljungman P, Paya CV (ed) Transplant infections. Lippincott-Raven, Philadelphia, 1998: 325-38.
2. Kontoyiannis DP, Lewis RE. Toward more effective antifungal therapy: the prospects of combination therapy. Br J Haematol 2004; 126 (2): 165-75.
3. Maertens J, Raad I, Petrikkos G, et al. Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy. Clin Infect Dis 2004; 39 (11): 1563-71.
4. Walsh TJ, Teppler H, Donowitz GR, et al. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. N Engl J Med 2004; 351 (14): 1391-402.
5. Cesaro S, Toffolutti T, Messina C, et al. Safety and efficacy of caspofungin and liposomal amphotericin B, followed by voriconazole in young patients affected by refractory invasive mycosis. Eur J Haematol 2004; 73 (1): 50-5.
6. Aliff TB, Maslak PG, Jurcic JG, et al. Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin. Cancer 2003; 97 (4): 1025-32.
7. Maertens J, Glasmacher A, Herbrecht R, et al. Multicenter noncomparative study of caspofungin combined with other antifungals in adults with invasive aspergillosis refractory or intolerant to standard regimens. Program and abstracts of the 44th Interscience Conference of Antimicrobial Agents and Chemotherapy; October 30-November 2, 2004; Washington, DC. Abstract 3718.
8. Kontoyiannis DP, Hachem R, Lewis RE, et al. Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies. Cancer 2003; 98 (2): 292-9.
9. Hubel K, Chemnitz J, Brochhagen HG, Cornely OA. Successful treatment of chronic disseminated candidiasis with caspofungin and itraconazole in a patient with progressive acute leukemia and prolonged neutropenia. Int J Hematol 2004; 79 (3): 289-92.
10. Tsiodras S, Zafiropoulou R, Giotakis J, Imbrios G, Antoniades A, Manesis EK. Deep sinus aspergillosis in a liver transplant recipient successfully treated with a combination of caspofungin and voriconazole. Transpl Infect Dis 2004; 6 (1): 37-40.
11. Marr KA, Boeckh M, Carter RA, Kim HW, Corey L. Combination antifungal therapy for invasive aspergillosis. Clin Infect Dis 2004; 39 (6): 797-802.
12. Damaj G, Ivanov V, Le Brigand B, et al. Rapid improvement of disseminated aspergillosis with caspofungin/voriconazole combination in an adult leukemic patient. Ann Hematol 2004; 83 (6): 390-3.
13. Kirkpatrick WR, Perea S, Coco BJ, Patterson TF. Efficacy of caspofungin alone and in combination with voriconazole in a Guinea pig model of invasive aspergillosis. Antimicrob Agents Chemother 2002; 46 (8): 2564-8.
14. Petraitis V, Petraitiene R, Sarafandi AA, et al. Combination therapy in treatment of experimental pulmonary aspergillosis: synergistic interaction between an antifungal triazole and an echinocandin. J Infect Dis 2003; 187 (12): 1834-43.
15. Elanjikal Z, Sorensen J, Schmidt H, et al. Combination therapy with caspofungin and liposomal amphotericin B for invasive aspergillosis. Pediatr Infect Dis J 2003; 22 (7): 653-6.
16. Castagnola E, Machetti M, Cappelli B, et al. Caspofungin associated with liposomal amphotericin B or voriconazole for treatment of refractory fungal pneumonia in children with acute leukaemia or undergoing allogeneic bone marrow transplant. Clin Microbiol Infect 2004; 10 (3): 255-7.
17. Odio CM, Araya R, Pinto LE, et al. Caspofungin Therapy of Neonates With Invasive Candidiasis. Pediatr Infect Dis J 2004; 23 (12): 1093-7.
18. Wertz KK, Pretzlaff RK. Caspofungin in a pediatric patient with persistent candidemia. Pediatr Crit Care Med 2004; 5 (2): 181-3.
19. Franklin JA, McCormick J, Flynn AM. Retrospective study of the safety of caspofungin in immunocompromised pediatric patients. Pedatr Inf Dis J 2003; 22: 747-9.